Form 8-K - Current report:
SEC Accession No. 0001437749-21-006529
Filing Date
2021-03-18
Accepted
2021-03-18 17:16:03
Documents
16
Period of Report
2021-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20210305_8k.htm   iXBRL 8-K 30364
2 EXHIBIT 10.1 ex_233471.htm EX-10.1 115397
3 EXHIBIT 99.1 ex_235105.htm EX-99.1 18965
8 ex_235105img001.jpg GRAPHIC 2561
  Complete submission text file 0001437749-21-006529.txt   328895

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dyai-20210318.xsd EX-101.SCH 3700
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20210318_def.xml EX-101.DEF 11586
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20210318_lab.xml EX-101.LAB 15466
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20210318_pre.xml EX-101.PRE 11740
9 EXTRACTED XBRL INSTANCE DOCUMENT dyai20210305_8k_htm.xml XML 2579
Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477
Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 21755398
SIC: 2836 Biological Products, (No Diagnostic Substances)